Nvidia will likely capture the largest percentage of the exponential compute demand. Read why I think the AI world is ...

Microsoft (NASDAQ:MSFT) presents its latest financial quarterly results and outlook next week, and the analysts at Evercore ...

While most market watchers have focused on the wildly yo-yoing stock market over the last few weeks, the Treasury bond market ...

Full year revenue guidance calls for just 4.4% growth at the midpoint, with adjusted EBITDA margin expected to improve 200 ...

Tesla, Inc. Q1 results disappointed with revenue, earnings miss & pulled guidance, but an inflection point may unlock massive valuation. Click for my TSLA update.

Bristol-Myers Squibb raised its 2025 EPS outlook after a Q1 beat, with shares trading far below historical P/E levels. Find ...

Ant Group agreed to acquire a 50.55% stake in Bright Smart Securities & Commodities Group, a Hong Kong retail broker, for ...

A report from industry trade group Pharmaceutical Research and Manufacturers of America (PhRMA), conducted by Ernst & Young, ...

Expanding features up the sales cycle, along with a superior price to product value is allowing MNDY to increase the portion ...

Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to expect from LLY's Q1 results.

Stay updated on lithium market trends, price shifts, EU-funded projects, U.S. critical minerals, and key developments from ...